Home » Topics » Conferences

Conferences
RSS

Schedule-dependent antitumor activity demonstrated for new modified steroidal lactams

March 3, 2000

Feasibility of HSV-TK/GCV gene therapy demonstrated in glioblastoma multiforme

March 2, 2000

Alimta, a multitargeted antifolate: clinical experience outlined at ICACT

March 1, 2000

Phase I results support further evaluation of i.v. R-101933 + paclitaxel

March 1, 2000

Ono-2506 has protective and therapeutic efficacy in EAN

March 1, 2000

Role of dietary factors discussed at cardiovascular disease conference

March 1, 2000

Monoclonal antibody targeting Lewis X combined with chemotherapy in breast cancer

Feb. 29, 2000

Positive early clinical results for decitabine in advanced NSCLC

Feb. 29, 2000

Safety and efficacy of seocalcitol examined in phase II colorectal cancer study

Feb. 29, 2000

New selectin inhibitor SKK-60060 shows promise in treatment of uveitis

Feb. 22, 2000

Popular Stories

Today's news in brief
BioWorld
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...